Business Wire

Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, Join a Growing List of Provinces Providing Public Drug Plan Reimbursement for Teva Canada’s AJOVY® (fremanezumab), for the Preventive Treatment of Migraine in Adults

Public formulary and program coverage makes AJOVY® accessible to more migraine patients across Canada MONTRÉAL--(BUSINESS WIRE)--Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., welcomes the recently announced public formulary

More

Oragenics Issues Letter to Shareholders

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) today issued the following letter to shareholders from its Executive Chairman, Frederick W. Telling, Ph.D.: To My Fellow Shareholders, I am please

More

SunOpta Inc. to Participate in Upcoming Investor Conferences

MINNEAPOLIS--(BUSINESS WIRE)--SunOpta Inc. ("SunOpta") (Nasdaq:STKL) (TSX:SOY) a U.S.-based, global pioneer fueling the future of sustainable, plant-based and fruit-based food and beverages, today announced that Joseph Ennen, Chief Executive Officer and S

More

AESARA, Inc. to Expand European Presence into Zug, Switzerland

LONDON & CHAPEL HILL, N.C. & TORONTO--(BUSINESS WIRE)--#Europe--AESARA (www.aesara.com) is pleased to announce expansion of its European operations by establishing a new hub in Zug, Switzerland, in May 2022. Gavin Outteridge, General Manager for AESARA E

More